[On the pharmacology of Ponalid, a new central anticholinergic].
D018680:Cholinergic Antagonists; D006801:Humans; D009069:Movement Disorders; D010276:Parasympatholytics; D010300:Parkinson Disease
D018680:Cholinergic Antagonists; D010276:Parasympatholytics
MOVEMENT DISORDERS; PARALYSIS AGITANS; PARASYMPATHOLYTICS